Title：Real-time Technology Platform for Cancer Detection and Classification

Field：Biomedicine

Claim：Equity investment

Brief：Novascan has established a real-time technology platform for cancer detection and classification. Marginscan, designed by novascan technology platform, has been able to provide accurate diagnosis of skin cancer, and has become a more rapid, economic and small amount of detection method for healthy tissues. Novascan also has the potential to integrate with other widely used instrument platforms.

Contact：BAI Lufeng

E-mail：hbst2015@126.com